Delivery Order SPE2DB24D1006-SPE2DB25FCEUX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,172.66 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on October 28, 2025, with completion scheduled for October 29, 2025. The award utilized firm fixed price pricing with no set-aside designation, indicating the contract was competitively awarded. Performance will be executed from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,569.17 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,156.03 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of May 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a $4,168.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Teriparatide 560mcg/2.24ml pens. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award is non-set-aside and was competitively awarded. Performance will be completed by July 25,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,502.63 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 MCG/2.24 ML pens on November 14, 2025. This firm fixed-price delivery order is set to be completed by November 17, 2025 and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement without set-aside designation, reflecting AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order valued at $32,094.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,676.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on June 6, 2025, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award represents a medical pharmaceutical delivery under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,171.60 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560MCG/2.24ML pens on November 4, 2025, with completion scheduled for November 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of...
- The Defense Logistics Agency awarded a $7,010.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24mL pen pharmaceutical products, with an ultimate completion date of November 6, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $19,742.16 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Teriparatide 560mcg/2.24mL pens. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet...
- SPE2DB24D1006Indefinite Delivery Contract
- SPE2DB24D1006-SPE2DB25FCEUXDelivery Order
The Defense Logistics Agency (DLA) awarded a $5,949.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24mL pens with a completion date of June 25, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems, leveraging its extensive pharmaceutical distribution capabilities to fulfill federal requirements. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The delivery order demonstrates the contractor's capability to meet federal medical supply needs through open competition, as part of broader Defense Health Agency procurement supporting military personnel and veteran populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 6/24/25 |